VLTO Stock Analysis: Veralto | NYSE
Pollution & Treatment Controls | NYSE, USA | Market Cap: 23.897m USD | 12M Return: -7.7% | US92338C1036 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 158M
Qual. Beats: 4
Rev. Trend: 98.8%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 2.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Veralto Corporation (NYSE: VLTO) is a global provider of water analytics, water treatment, marking and coding, and packaging and color solutions, operating through two reportable segments: Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment supplies precision instrumentation, water treatment technologies, chemical reagents, and related software under brands such as Hach, Trojan Technologies, and ChemTreat, serving residential, commercial, municipal, industrial, research, and natural resource applications. The PQI segment delivers marking and coding systems, digital asset and product information management software, inline printing solutions, packaging design and imaging tools, and color management and standard services under the Videojet, Linx, Esko, X-Rite, and Pantone brands, targeting industries such as municipal utilities, food and beverage, pharmaceutical, and broader industrials.
The company is classified within the Industrials sector and the Environmental & Facilities Services sub-industry, reflecting its exposure to regulated and essential end markets such as water utility infrastructure and consumer goods packaging. Veralto was incorporated in 2022 and was originally named DH EAS Holding Corp., having been spun off from Danaher Corporation; it adopted the Veralto name in February 2023 and completed its IPO in October 2023. The company is headquartered in Waltham, Massachusetts, and operates a B2B business model in which sales are driven by regulatory requirements, recurring consumables and reagents, and long-tenured relationships with industrial and municipal customers.
- Municipal water infrastructure spending accelerates Water Quality segment growth
- PFAS and clean water regulations boost Hach analytics and Trojan UV demand
- PQI marking and coding sales track global packaging volumes across food and pharma
- ChemTreat recurring reagent revenue expands margins through industrial water treatment contracts
| Net Income: 988.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.92 > 1.0 |
| NWC/Revenue: 28.00% < 20% (prev 31.29%; Δ -3.29% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.10b > Net Income 988.0m |
| Net Debt (1.47b) to EBITDA (1.39b): 1.06 < 3 |
| Current Ratio: 1.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (245.8m) vs 12m ago -1.64% < -2% |
| Gross Margin: 60.18% > 18% (prev 59.88%; Δ 0.30% > 0.5%) |
| Asset Turnover: 72.43% > 50% (prev 74.77%; Δ -2.35% > 0%) |
| Interest Coverage Ratio: 14.08 > 6 (EBIT TTM 1.29b / Interest Expense TTM 92.0m) |
| A: 0.19 (Total Current Assets 3.65b - Total Current Liabilities 2.06b) / Total Assets 8.56b |
| B: 0.25 (Retained Earnings 2.17b / Total Assets 8.56b) |
| C: 0.16 (EBIT TTM 1.29b / Avg Total Assets 7.86b) |
| D: 0.57 (Book Value of Equity 3.10b / Total Liabilities 5.46b) |
| Altman-Z'' = 3.75 = AA |
| DSRI: 0.99 (Receivables 921.0m/878.0m, Revenue 5.70b/5.36b) |
| GMI: 1.00 (GM 59.88% / 60.18%) |
| AQI: 0.98 (AQ_t 0.54 / AQ_t-1 0.55) |
| SGI: 1.06 (Revenue 5.70b / 5.36b) |
| TATA: -0.01 (NI 988.0m - CFO 1.10b) / TA 8.56b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of August 10, 2026, the stock is trading at USD 98.34 with a total of 830,696 shares traded. Over the past week, the price has changed by +4.43%, over one month by +6.78%, over three months by +13.76% and over the past year by -7.72%.
Current recommended Stop Loss: 94.70 (which is 3.7% or 1.4 ATR below the current price).
Veralto has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy VLTO.
- StrongBuy: 9
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 113 | 14.9% |
P/E Trailing = 24.4439
P/E Forward = 21.3675
P/S = 4.1953
P/B = 7.413
P/EG = 2.4266
Revenue TTM = 5.70b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 2.68b USD (from longTermDebt, last quarter)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 3.58b USD (from shortLongTermDebtTotal, last quarter) + Leases 206.0m
Net Debt = 1.47b USD (calculated: Debt 3.58b - CCE 2.12b)
Enterprise Value = 25.4b USD (23.9b + Debt 3.58b - CCE 2.12b)
Interest Coverage Ratio = 14.08 (Ebit TTM 1.29b / Interest Expense TTM 92.0m)
EV/FCF = 24.22x (Enterprise Value 25.4b / FCF TTM 1.05b)
FCF Yield = 4.13% (FCF TTM 1.05b / Enterprise Value 25.4b)
FCF Margin = 18.38% (FCF TTM 1.05b / Revenue TTM 5.70b)
Net Margin = 17.35% (Net Income TTM 988.0m / Revenue TTM 5.70b)
Gross Margin = 60.18% ((Revenue TTM 5.70b - Cost of Revenue TTM 2.27b) / Revenue TTM)
Gross Margin QoQ = 61.19% (prev 60.06%)
Tobins Q-Ratio = 2.96 (Enterprise Value 25.4b / Total Assets 8.56b)
Interest Expense / Debt = 2.57% (Interest Expense 92.0m / Debt 3.58b)
Taxrate = 18.28% (221.0m / 1.21b)
NOPAT = 1.06b (EBIT 1.29b * (1 - 18.28%))
Current Ratio = 1.78 (Total Current Assets 3.65b / Total Current Liabilities 2.06b)
Debt / Equity = 1.16 (Debt 3.58b / totalStockholderEquity, last quarter 3.10b)
Debt / EBITDA = 1.06 (Net Debt 1.47b / EBITDA 1.39b)
Debt / FCF = 1.40 (Net Debt 1.47b / FCF TTM 1.05b)
Total Stockholder Equity = 3.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.56% (Net Income 988.0m / Total Assets 8.56b)
RoE = 32.79% (Net Income TTM 988.0m / Total Stockholder Equity 3.01b)
RoCE = 22.75% (EBIT 1.29b / Capital Employed (Equity 3.01b + L.T.Debt 2.68b))
RoIC = 15.30% (NOPAT 1.06b / Invested Capital 6.92b)
WACC = 6.62% (E(23.9b)/V(27.5b) * Re(7.30%) + D(3.58b)/V(27.5b) * Rd(2.57%) * (1-Tc(0.18)))
Discount Rate = 7.30% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -31.87 | Cagr: -0.54%
[DCF] Terminal Value 76.78% ; FCFF base≈1.01b ; Y1≈1.10b ; Y5≈1.39b
[DCF] Fair Price = 81.07 (EV 21.2b - Net Debt 1.47b = Equity 19.8b / Shares 243.8m; r=8.35% [WACC [floored]]; 5y FCF grow 11.03% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 4.0 | # QB: 4
Revenue Correlation: 98.81 | Revenue CAGR: 5.08% | SUE: 1.00 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.09 | Chg30d=+1.14% | Revisions=-50% | Analysts=15
EPS current Year (2026-12-31): EPS=4.39 | Chg30d=+3.16% | Revisions=+22% | GrowthEPS=+12.5% | GrowthRev=+7.3%
EPS next Year (2027-12-31): EPS=4.77 | Chg30d=+2.45% | Revisions=+30% | GrowthEPS=+8.8% | GrowthRev=+5.2%
[Analyst] Revisions Ratio: +11% (up=9, down=7)